Neuroimaging in Patients with Olfactory Dysfunction
AJR 162:411-418, Li,C.,et al, 1994
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
Front Neurol doi:10.3389/fneur.2017.00472, Velazquez-Perez, L.C.,et al, 2017
Invited Article: Nervous System Pathology in Sporadic Parkinson Disease
Neurol 70:1916-1925, Braak,H. & Del Tredici,K., 2008
The Parkinsons Complex: Parkinsonism Is Just the Tip of the Iceberg
Ann Neurol 59:591-596, Langston,J.W., 2006
Why Should Neuroradiologist Study Patients with Smell Loss?
AJNR 24:556-557, Levy,L.M.&Henkin,R.I., 2003
Staging of Brain Pathology Related to Sporadic Parkinsons Disease
Neurobiol Aging 24:197-211, Braak,H.,et al, 2003
Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999
Mapping Brain Activation to Odorants in Patients with Smell Loss by Functional MRI
J Comput Assist Tomogr 22:96-103, Levy,L.M.,et al, 1998
Increased Brain Activa in Resp to Odors in Pts with Hyposmia after Theophylline Trtm by fMRI
J Comput Assist Tomogr 22:760-770, Levy,L.M.,et al, 1998
Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997
Olfactory Dysfunction in Patients with Head Trauma
Arch Neurol 54:1131-1140, Doty,R.L.,et al, 1997
Olfactory Dysfunction in Parkinson's Disease
JNNP 62:436-446, Hawkes,C.H.,et al, 1997
MR Evaluation of Patients with Congenital Hyposmia or Anosmia
AJR 166:439-443, Yousem,D.M.,et al, 1996
Posttraumatic Olfactory Dysfunction:MR and Clinical Evaluation
AJNR 17:1171-1179, Yousem,D.M.,et al, 1996
Olfactory Neuroblastoma: MR Evaluation
AJNR 14:1167-1171, Li, C.,et al, 1993
Wolfram Syndrome:Evidence of a Diffuse Neurodegenerative Disease by Magnetic Resonance Imaging
Neurol 42:1220-1224, 1992,, Rando,T.A.,et al, 1992